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luoroscopy use has increased recently
because of the growing use of minimally
invasive surgical procedures. Fluoroscopy,
and other procedures using radiation exposure, can
induce acute and chronic skin damage. Diagnosis of
fluoroscopy-induced chronic radiation dermatitis
(FICRD) is challenging as patients are sometimes
unaware of exposure to radiation and presentation
often occurs after months or years.1,2 Early recogni-
tion is important to optimize both therapy and
surveillance for radiation-induced malignancies.1
We present a case of a 72-year-old manwith a greater
than 1-year history of a nonhealing ulcer on the back.
He had a history of endovascular abdominal aortic
aneurysm repair with subsequent endoleak repairs,
which required intraoperative use of fluoroscopy.
CASE REPORT
A 72-year-oldmanwith a complexmedical history
significant for abdominal aortic aneurysm status
postrepair and morbid obesity (body mass index
46 kg/m2) presented to our dermatology clinic with a
greater than 1-year history of a painful nonhealing
ulcer involving the lower aspect of his back. One
year before presentation, the patient was treated
with a 10-day course of acyclovir for a presumed
diagnosis of herpes zoster of the corresponding area.
Approximately 6 months before presentation, the
patient underwent excisional debridement of the site
and a course of antibiotics for worsening and pro-
gression of a presumed stage III decubitus ulcer. The
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care efforts. On presentation, physical examination
revealed a sclerotic plaque with telangiectasia and a
5-cm ulceration in the central portion of the lesion on
the lower aspect of the back (Fig 1). Biopsy
specimens from the lateral aspect of the plaque
revealed dermal sclerosis with focal atypical fibro-
blasts and dilated superficial blood vessels consistent
with radiation dermatitis (Fig 2). Further investiga-
tion of the patient’s surgical history revealed 3
endovascular abdominal aortic aneurysm endoleak
repairs over the course of 3 years. The cumulative
operative time for the 3 procedures exceeded
14 hours, and fluoroscopy had been used exten-
sively during each procedure. Given the patient’s
history of prolonged fluoroscopic exposure corre-
sponding to the site of involvement, and the clinical
and histopathologic findings characteristic of radia-
tion dermatitis, the diagnosis of FICRD was estab-
lished. Shortly after diagnosis, the patient was
hospitalized for management of a pseudomonal
infection of the ulcer and underlying osteomyelitis.
Despite treatment with intravenous antibiotics, the
patient continued to deteriorate. After consultation
with general surgery, the patient was deemed a poor
surgical candidate and was discharged home with
hospice care where he died shortly thereafter.
DISCUSSION
Fluoroscopy provides real-time radiologic visual-
ization during a variety of interventional and
diagnostic procedures.3 The rate of fluoroscopicJAAD Case Reports 2015;1:403-5.
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Fig 1. Patient at initial presentation to the dermatology clinic: entire back (A) and area of
interest (B).
Fig 2. Histopathology demonstrating dermal sclerosis, focal atypical fibroblasts, and dilated
superficial blood vessels. (A and B, Hematoxylin-eosin stain; original magnifications: A, 3100;
B, 3500.)
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404 Lyons, Harvey, and Gusevprocedures has been increasing with the majority of
fluoroscopy-associated radiation dermatitis cases
occurring after interventional cardiac procedures.
Despite its widespread use, the incidence of
radiation-induced skin injury from fluoroscopy is
estimated to be less than 0.01%4; to date, over 100
cases have been reported in the literature.
Radiation dermatitis is categorized as acute, sub-
acute, or chronic. Acute radiation dermatitis may
occur up to 9 weeks after exposure and is charac-
terized by erythema, desquamation, edema, and
possible skin necrosis and ulceration. Chronicradiation dermatitis occurs months to years
after exposure and typically features permanent
erythema and telangiectasias, skin fragility, ulcera-
tion, loss of follicular structures, late-onset dermal
necrosis, and secondary cutaneousmalignancies.1,2,5
Histologically confirmed radiation dermatitis reveals
ulceration, prominent telangiectasias, atypical stel-
late fibroblasts, epidermal atrophy, and absence of
inflammation.1
The extent of skin toxicity correlates directly with
exposure dose and ranges from early transient
ischemia (2 Gy), permanent erythema (7 Gy),
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secondary ulceration (20 Gy).6 FICRD usually occurs
after exposure to radiation doses of 10 Gy or higher.1
A typical fluoroscopic procedure emits 0.02 to
0.05 Gy per minute with the average cardiac cathe-
terization using approximately 2.5 Gy.2 Operative
records reveal that our patient was exposed to at
least 25 Gy (exposure dosage was not documented
for 2010 fluoroscopic procedure).
The radiation threshold required to cause skin
injury is patient-specific and depends on multiple
factors.4 Treatment-related factors contributing to
skin toxicity include higher radiation doses, short
intervals between radiation exposures, size of irra-
diated site, and case complexity.1,4 Patient-specific
factors include smoking, obesity, and poor nutri-
tional status.1,4 Obese patients, such as the patient
described in this report, require higher radiation
output to penetrate the excess adipose tissue,
resulting in radiation doses up to 3 times that for a
person with a normal body mass index.7 Common
sites of FICRD correspond to the sites of ionizing
radiation beam entry during fluoroscopic proce-
dures and include the axilla, scapula, and mid aspect
of the back.1,5
Treatment of radiation dermatitis can include
topical steroids or surgical excision with skin graft-
ing, but there are no guidelines on definitive
treatment.1,5 Provider education is essential for the
prevention of FICRD. Precautionseincluding sur-
veillance of radiation dosage and minimization of
the area exposed to radiationecan help limit com-
plications.6 A study by Kirkwood et al7 found that
educating vascular surgeons on better operating
practices (including limiting fluoroscopy time, using
pulsed fluoroscopy, and minimizing patient-to-
detector distance) lowered radiation dose to the
skin. Accordingly, radiation safety lectures can help
raise physician awareness of FICRD and help lower
radiation exposure during procedures.7 Providers
should counsel patients on the possibility of acute
radiation dermatitis and FICRD and instruct them tomonitor for any cutaneous signs or symptoms. Close
follow-up is essential to monitor for progression and
malignant transformation into squamous cell carci-
noma or basal cell carcinoma.8
Because of the low incidence of FICRD, primary
care physicians, interventional radiologists, sur-
geons, and dermatologists often are unaware of its
existence. Radiation dermatitis should be considered
in any patient with previous fluoroscopy or other
type of radiation exposure who presents with
characteristic skin changes, including nonhealing
ulcers. A thorough history should be obtained from
these patients, with an emphasis on past fluoro-
scopic procedures. Understanding the patient’s med-
ical and surgical history, along with the site of
lesions, clinical presentation, and characteristic his-
topathologic findings are vital in establishing a
diagnosis of FICRD.REFERENCES
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